Avanos Medical Stock
Avanos Medical, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- David C. Pacitti
- Employees
- 2,287
- Market cap
- $1.2 B
- IPO
- 21/10/2014
- Web
- avanos.com
Avanos Medical, Inc. is a medical technology enterprise operating within the healthcare sector on an international scale. Headquartered in Alpharetta, the company provides specialized solutions across North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product…
Company description based on the data provider's company data, AI-assisted, created on 17/10/2026. Not investment advice.
Avanos Medical stock: price history
1D
+0.0%
1W
+0.1%
1M
+0.2%
6M
+90.9%
YTD
+122.5%
1Y
+110.4%
2Y
+10.6%
5Y
-28.1%
10Y
-27.1%
Next earnings date
Next earnings date
No date known
Volatility around earnings
~60% stronger price swings than usual
Avanos Medical stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Ask the agents about Avanos Medical
Analyst assessment of Avanos Medical
PRICE TARGET LOW
US$20.00
CONSENSUS
US$23.00
MEDIAN
US$23.00
PRICE TARGET HIGH
US$26.00
0
STRONG BUY
1
BUY
6
HOLD
1
SELL
0
STRONG SELL
8
TOTAL · Hold
As of: 25/07/2023
Avanos Medical stock metrics
P/E
-16.65
P/B
1.48
EV/EBITDA
-57.57
RETURN ON EQUITY
0.7%
NET MARGIN
2.8%
DEBT/EQUITY
0.18
DIVIDEND YIELD
0.0%
AS OF
31/03/2026
Free float & liquidity
FREE FLOAT
98.2%
FLOAT SHARES
46,026,430
AVG. DAILY VOLUME (30D)
840,697
Insider transactions (SEC)
BLACKFORD GARY
BLACKFORD GARY
Egbuonu-Davis Lisa
Franchini Indrani Lall
OLEARY PATRICK J
Institutional holders
Smart Money
Register for free
Register now to see which funds are invested
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Comparable stocks
Frequently asked questions about Avanos Medical stock
What does Avanos Medical do?
Avanos Medical, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is David C. Pacitti, the company employs around 2,287 people.
The IPO was on 21/10/2014; the stock trades on NYSE under the ticker AVNS.
What do analysts say about Avanos Medical stock?
8 analysts rate the stock, the consensus is Hold (as of 25/07/2023).
The average price target is US$23.00, ranging from US$20.00 to US$26.00, with a median of US$23.00.
This is an external assessment, not a statement by Market Jury.
When does Avanos Medical report next?
Around past earnings, price swings were roughly 60% stronger than usual.
Does Avanos Medical pay a dividend?
No, Avanos Medical currently does not pay a dividend.
Which stocks are comparable to Avanos Medical?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Avanos Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Avanos Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.